3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
4
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Neoplasms
2
Ototoxicity
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Laryngeal Diseases
1
Hearing Loss
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Gallbladder Cancer Unresectable
1
Esophageal Squamous Cell Carcinoma
1
Cognitive Dysfunction
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
3
sintilimab
2
toripalimab
1
camrelizumab
1
anlotinib
1
TP protocol
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
Nivolumab
1
Neoadjuvant Therapy
1
Immune Checkpoint Inhibitors
1
Fluorouracil
1
Docetaxel
1
Chemoradiotherapy
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Esophageal Squamous Cell Carcinoma
×
Chemoradiotherapy
×
Clear all
NCT04328948
2025-05-22
ARMADILLO
National Cancer Center, Japan
Phase 3
Recruiting
280 enrolled